Pfizer says new experimental Covid pill reduces risk of hospitalization, death

Home*Cover Story*Covid-19 Coronavirus

Pfizer says new experimental Covid pill reduces risk of hospitalization, death

Drugmaker Pfizer said Friday its experimental pill designed to fight coronavirus reduced the risk of hospitalization and death for high-risk patients taking part in a trial of the drug.

The Company says it hopes it can eventually offer the pill, given in combination with an older antiviral drug called ritonavir, to people to take at home before they get sick enough to go to the hospital.

A so-called interim analysis — done before the trial was scheduled to end — showed an 89% reduction in the risk of hospitalization or death from Covid-19 if patients got it soon enough, the company said.

Pfizer President Albert Bourla spoke with CNN on the news.

COMMENTS

WORDPRESS: 0
DISQUS: 0